{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:53:13Z","timestamp":1786593193568,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Interstitial lung disease (ILD) is frequently associated with collagen diseases. The prognosis of acute-onset diffuse ILD (AoDILD) occurring in collagen disease patients is very poor. Here, we investigated serum biomarker profiles of AoDILD to find markers predicting outcome in patients with collagen diseases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A solid-phase antibody array was used for screening 274 biomarkers in pooled sera from collagen disease patients in the AoDILD state and in the stable state. Biomarkers in individual sera were detected without pooling by bead-based immunoassay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The serum levels of matrix metalloproteinase (MMP)-1, tissue inhibitor of metalloproteinase (TIMP)-1, osteopontin, interleukin (IL)-2 receptor \u03b1(IL-2R\u03b1), and IL-1 receptor antagonist were significantly increased in AoDILD, but TIMP-2, MMP-3, and eotaxin 2 levels were decreased. The MMP-3 to MMP-1 ratio was reduced in AoDILD state. This tendency was also observed in RA patients with AoDILD. Moreover, serum IL-6 level was significantly increased in the AoDILD state in patients with acute exacerbation of ILD (AE-ILD). Serum TIMP-1 and IL-2R\u03b1 levels were significantly increased in the AoDILD state in patients with drug-induced ILD (DI-ILD), whereas TIMP-2, MMP-3, and eotaxin 2 levels were decreased. The MMP-3 to MMP-1 ratio was reduced in AoDILD state in patients with DI-ILD. The serum TIMP-3,MMP-9, osteopontin, IL-2R\u03b1, MMP-1, and MMP-8 levels were significantly increased in the AoDILD state in patients who subsequently died, whereas TIMP-2 and MMP-3 levels were decreased in those who survived. The MMP-3 to MMP-1 ratio was reduced in AoDILD state in patients who died, but not in those who survived.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Serum biomarker profiles could represent prognosis markers for AoDILD in collagen diseases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2172-14-9","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T05:15:05Z","timestamp":1360818905000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Serum biomarker analysis of collagen disease patients with acute-onset diffuse interstitial lung disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Shomi","family":"Oka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoshi","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Tohma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,14]]},"reference":[{"key":"513_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/03009740310004621","volume":"33","author":"C Turesson","year":"2004","unstructured":"Turesson C, Jacobsson LT: Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol. 2004, 33: 65-72. 10.1080\/03009740310004621.","journal-title":"Scand J Rheumatol"},{"key":"513_CR2","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","volume":"49","author":"G Koduri","year":"2010","unstructured":"Koduri G, Norton S, Young A, Cox N, Davies P, Devlin J, Dixey J, Gough A, Prouse P, Winfield J, et al: Interstitial lung disease has a poor prognosis in rheumatoid arthritis:results from an inception cohort. Rheumatology. 2010, 49: 1483-1489. 10.1093\/rheumatology\/keq035.","journal-title":"Rheumatology"},{"key":"513_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2169\/internalmedicine.50.4508","volume":"50","author":"H Kameda","year":"2011","unstructured":"Kameda H, Tokuda H, Sakai F, Johkoh T, Mori S, Yoshida Y, Takayanagi N, Taki H, Hasegawa Y, Hatta K, et al: Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study. Intern Med. 2011, 50: 305-313. 10.2169\/internalmedicine.50.4508.","journal-title":"Intern Med"},{"key":"513_CR4","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1164\/ajrccm.154.2.8756805","volume":"154","author":"B Ricou","year":"1996","unstructured":"Ricou B, Nicod L, Lacraz S, Welgus HG, Suter PM, Dayer JM: Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. Am J Respir Crit Care Med. 1996, 154: 346-352.","journal-title":"Am J Respir Crit Care Med"},{"key":"513_CR5","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1164\/ajrccm.162.5.9906096","volume":"162","author":"M Suga","year":"2000","unstructured":"Suga M, Iyonaga K, Okamoto T, Gushima Y, Miyakawa H, Akaike T, Ando M: Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2000, 162: 1949-1956.","journal-title":"Am J Respir Crit Care Med"},{"key":"513_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2174\/1389203023380549","volume":"3","author":"H Ohbayashi","year":"2002","unstructured":"Ohbayashi H: Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci. 2002, 3: 409-421. 10.2174\/1389203023380549.","journal-title":"Curr Protein Pept Sci"},{"key":"513_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002\/art.1780310302.","journal-title":"Arthritis Rheum"},{"key":"513_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","unstructured":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980, 23: 581-590. 10.1002\/art.1780230510.","journal-title":"Arthritis Rheum"},{"key":"513_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975, 292: 344-347. 10.1056\/NEJM197502132920706.","journal-title":"N Engl J Med"},{"key":"513_CR10","doi-asserted-by":"crossref","first-page":"L562","DOI":"10.1152\/ajplung.2000.279.3.L562","volume":"279","author":"M Selman","year":"2000","unstructured":"Selman M, Ruiz V, Cabrera S, Segura L, Ramirez R, Barrios R, Pardo A: TIMP-1, -2, -3, and \u22124 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?. Am J Physiol Lung Cell Mol Physiol. 2000, 279: L562-L574.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"513_CR11","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1371\/journal.pmed.0050093","volume":"5","author":"IO Rosas","year":"2008","unstructured":"Rosas IO, Richards TJ, Konishi K, Zhang Y, Gibson K, Lokshin AE, Lindell KO, Cisneros J, Macdonald SD, Pardo A, et al: MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med. 2008, 5: e93-10.1371\/journal.pmed.0050093.","journal-title":"PLoS Med"},{"key":"513_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.humpath.2005.11.023","volume":"37","author":"SE Fligiel","year":"2006","unstructured":"Fligiel SE, Standiford T, Fligiel HM, Tashkin D, Strieter RM, Warner RL, Johnson KJ, Varani J: Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury. Hum Pathol. 2006, 37: 422-430. 10.1016\/j.humpath.2005.11.023.","journal-title":"Hum Pathol"},{"key":"513_CR13","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1371\/journal.pmed.0020251","volume":"2","author":"A Pardo","year":"2005","unstructured":"Pardo A, Gibson K, Cisneros J, Richards TJ, Yang Y, Becerril C, Yousem S, Herrera I, Ruiz V, Selman M, et al: Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med. 2005, 2: e251-10.1371\/journal.pmed.0020251.","journal-title":"PLoS Med"},{"key":"513_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.anai.2009.11.003","volume":"104","author":"M Kohan","year":"2010","unstructured":"Kohan M, Puxeddu I, Reich R, Levi-Schaffer F, Berkman N: Eotaxin-2\/CCL24 and eotaxin-3\/CCL26 exert differential profibrogenic effects on human lung fibroblasts. Ann Allergy Asthma Immunol. 2010, 104: 66-72. 10.1016\/j.anai.2009.11.003.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"513_CR15","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1164\/ajrccm.151.6.7767546","volume":"151","author":"DR Smith","year":"1995","unstructured":"Smith DR, Kunkel SL, Standiford TJ, Rolfe MW, Lynch JP, Arenberg DA, Wilke CA, Burdick MD, Martinez FJ, Hampton JN, et al: Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis. A compartmental analysis. Am J Respir Crit Care Med. 1995, 151: 1965-1973.","journal-title":"Am J Respir Crit Care Med"},{"key":"513_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1365-3083.2008.02222.x","volume":"69","author":"M Vasakova","year":"2009","unstructured":"Vasakova M, Sterclova M, Kolesar L, Slavcev A, Pohunek P, Sulc J, Skibova J, Striz I: Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases. Scand J Immunol. 2009, 69: 268-274. 10.1111\/j.1365-3083.2008.02222.x.","journal-title":"Scand J Immunol"},{"key":"513_CR17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000072007","volume":"70","author":"J Homolka","year":"2003","unstructured":"Homolka J, Ziegenhagen MW, Gaede KI, Entzian P, Zissel G, Muller-Quernheim J: Systemic immune cell activation in a subgroup of patients with idiopathic pulmonary fibrosis. Respiration. 2003, 70: 262-269. 10.1159\/000072007.","journal-title":"Respiration"},{"key":"513_CR18","doi-asserted-by":"publisher","first-page":"L3","DOI":"10.1152\/ajplung.90637.2008","volume":"299","author":"HR Collard","year":"2010","unstructured":"Collard HR, Calfee CS, Wolters PJ, Song JW, Hong SB, Brady S, Ishizaka A, Jones KD, King TE, Matthay MA, et al: Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2010, 299: L3-L7. 10.1152\/ajplung.90637.2008.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"513_CR19","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3899\/jrheum.081192","volume":"36","author":"M Lewicki","year":"2009","unstructured":"Lewicki M, Kotyla P, Kucharz E: Increased adiponectin levels in women with rheumatoid arthritis after etanercept treatment. J Rheumatol. 2009, 36: 1346-1347. 10.3899\/jrheum.081192.","journal-title":"J Rheumatol"},{"key":"513_CR20","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/j.rmed.2007.04.019","volume":"101","author":"GN Andersen","year":"2007","unstructured":"Andersen GN, Nilsson K, Pourazar J, Hackett TL, Kazzam E, Blomberg A, Waldenstrom A, Warner J, Rantapaa-Dahlqvist S, Mincheva-Nilsson L, et al: Bronchoalveolar matrix metalloproteinase 9 relates to restrictive lung function impairment in systemic sclerosis. Respir Med. 2007, 101: 2199-2206. 10.1016\/j.rmed.2007.04.019.","journal-title":"Respir Med"},{"key":"513_CR21","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1136\/annrheumdis-2011-200837","volume":"71","author":"M Manetti","year":"2012","unstructured":"Manetti M, Guiducci S, Romano E, Bellando-Randone S, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M: Increased serum levels and tissue expression of matrix metalloproteinase-12in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage. Ann Rheum Dis. 2012, 71: 1064-1072. 10.1136\/annrheumdis-2011-200837.","journal-title":"Ann Rheum Dis"},{"key":"513_CR22","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.2174\/092986709787846587","volume":"16","author":"S Oikonomidi","year":"2009","unstructured":"Oikonomidi S, Kostikas K, Tsilioni I, Tanou K, Gourgoulianis KI, Kiropoulos TS: Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications. Curr Med Chem. 2009, 16: 1214-1228. 10.2174\/092986709787846587.","journal-title":"Curr Med Chem"},{"key":"513_CR23","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/rheumatology\/ken086","volume":"47","author":"JK Ahn","year":"2008","unstructured":"Ahn JK, Koh EM, Cha HS, Lee YS, Kim J, Bae EK, Ahn KS: Role of hypoxia-inducible factor-1alpha in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes. Rheumatology (Oxford). 2008, 47: 834-839. 10.1093\/rheumatology\/ken086.","journal-title":"Rheumatology (Oxford)"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2172-14-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:20:48Z","timestamp":1630534848000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/1471-2172-14-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,14]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1186\/1471-2172-14-9","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,14]]},"assertion":[{"value":"30 October 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"9"}}